Intuition

Medical technology back on track

Retrieved on: 
Wednesday, March 13, 2024

The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.

Key Points: 
  • The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.
  • “We also anticipate a big boost in growth from the increasing use of artificial intelligence in the medical technology and healthcare services industries,” Stefan Blum adds.
  • These were generally characterized by strong growth momentum in surgical procedures and an optimistic outlook for the 2024 fiscal year,” Marcel Fritsch comments.
  • Elevance, which is focused on employer-sponsored health insurance plans, reported better-than-expected profits thanks to a drop in medical costs and an increase in management’s earnings guidance for 2024.

Elsevier Health Launches ClinicalKey AI, the Most Advanced Gen AI-Powered Clinical Decision Support Tool for Clinicians

Retrieved on: 
Thursday, February 29, 2024

New York, New York--(Newsfile Corp. - February 29, 2024) - Elsevier Health, a global leader in medical information and data analytics, today launched ClinicalKey AI, the first and most advanced clinical decision support tool to be introduced in the US that combines the latest and most trusted medical content with generative artificial intelligence (AI) to help clinicians at the point of care. ClinicalKey AI has been launched in partnership with OpenEvidence, a company specializing in AI for medicine.

Key Points: 
  • ClinicalKey AI has been launched in partnership with OpenEvidence, a company specializing in AI for medicine.
  • Our work with Elsevier Health has allowed us to deliver a superior user experience, combining trusted medical content with advanced AI technology through ClinicalKey AI.
  • ClinicalKey AI is built and maintained to deliver the accuracy and relevance of insights that healthcare institutions and physicians expect from Elsevier Health.
  • Attendees at the upcoming HIMSS Conference (March 11-15) can experience an in-person demonstration of ClinicalKey AI by visiting Elsevier at Booth 3048.

Pattern to Attend NVIDIA’s GTC 2024 Conference

Retrieved on: 
Monday, March 11, 2024

REDMOND, Wash., March 11, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will attend NVIDIA’s GTC 2024 Conference.

Key Points: 
  • REDMOND, Wash., March 11, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will attend NVIDIA’s GTC 2024 Conference.
  • During the conference, Pattern will conduct one-on-one meetings with investors and potential partners, showcasing the Company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.
  • To schedule a meeting with Pattern, please contact Pattern’s Executive Vice President of Special Projects, Denyse Hudson, at [email protected] .
  • Mr. Anderson commented, “Pattern uses proprietary pattern discovery techniques to perform high-dimensional data analytics in any field with significant data complexity.

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Jackie Schimmel's The Bitch Bible Podcast, Further Strengthening PodcastOne’s Thriving Network of Female Focused Programming

Retrieved on: 
Monday, March 4, 2024

LOS ANGELES, CA, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), which owns ~73% of the PODC outstanding common stock, announced today that it has acquired the exclusive sales and distribution rights to Jackie Schimmel’s The Bitch Bible Podcast. This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.

Key Points: 
  • This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.
  • As part of the newly announced partnership, Schimmel will begin to create video elements as a companion to her audio-based podcast.
  • “PodcastOne is thrilled to welcome Jackie and The Bitch Bible to the network.
  • PodcastOne shows are available through PodcastOne , Apple Podcasts, Spotify, iHeart, Amazon and wherever podcasts are heard.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Machines, Inc. - LUNR

Retrieved on: 
Wednesday, February 28, 2024

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Intuitive Machines, Inc. (“Intuitive Machines” or the “Company”) (NASDAQ: LUNR).

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Intuitive Machines, Inc. (“Intuitive Machines” or the “Company”) (NASDAQ: LUNR).
  • The investigation concerns whether Intuitive Machines and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 22, 2024, Intuitive Machines’ Odysseus lunar lander reached the surface of the Moon, making Intuitive Machines the first private company to land on the Moon.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti

Retrieved on: 
Monday, February 26, 2024

MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective time to undergo Ibogaine treatment.

Key Points: 
  • MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective time to undergo Ibogaine treatment.
  • Ibogaine Treatment Dardashti, founder of the Ibogaine Center in Miami, believes that the month of March may be the most effective time to undergo this treatment due to the alignment of electric currents.
  • "My research suggests that the Ibogaine treatment may be more effective in March", says Dardashti.
  • Dardashti suggests that the Ibogaine treatment may be more effective during the month of March due to the stabilization of electric currents, allowing individuals to develop a stronger intuition and potentially aiding their recovery process.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Intuitive Machines, Inc. (LUNR)

Retrieved on: 
Thursday, February 29, 2024

The law firm of Kirby McInerney LLP is investigating potential claims against Intuitive Machines, Inc. (“Intuitive Machines” or the “Company”) (NASDAQ: LUNR ).

Key Points: 
  • The law firm of Kirby McInerney LLP is investigating potential claims against Intuitive Machines, Inc. (“Intuitive Machines” or the “Company”) (NASDAQ: LUNR ).
  • The investigation concerns whether Intuitive Machines and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On February 22, 2024, Intuitive Machines’ Odysseus lunar lander reached the surface of the Moon, making Intuitive Machines the first private company to land on the Moon.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary

Retrieved on: 
Tuesday, February 20, 2024

Organon (NYSE: OGN), a global healthcare company with a dedicated commitment to biosimilars, announced that the US Department of Veterans Affairs (VA) has exclusively selected HADLIMA in replacement of HUMIRA (adalimumab) for the VA National Formulary.

Key Points: 
  • Organon (NYSE: OGN), a global healthcare company with a dedicated commitment to biosimilars, announced that the US Department of Veterans Affairs (VA) has exclusively selected HADLIMA in replacement of HUMIRA (adalimumab) for the VA National Formulary.
  • "America’s veterans deserve access to quality medicines at a lower cost.
  • “We applaud the VA for its leadership in championing biosimilars and including all three of Organon’s biosimilars available in the US on its formulary."
  • HADLIMA was launched in the US to offer patients a more affordable option without compromising on safety and efficacy.

Altimetrik Unveils a Market First Digital Business Methodology

Retrieved on: 
Monday, February 19, 2024

Altimetrik's unveiling of its Digital Business Methodology (DBM) leverages 10 years of experience in delivering outcomes and growth for customers.

Key Points: 
  • Altimetrik's unveiling of its Digital Business Methodology (DBM) leverages 10 years of experience in delivering outcomes and growth for customers.
  • The paradigm has shifted from digital transformation to digital business, and here businesses take the ownership to drive the outcomes by taking a holistic approach.
  • Altimetrik facilitates internalization of digital skills and culture, enabling clients to identify talent both internally and externally through the Digital Business Academy (DBA).
  • Altimetrik is a digital business pioneer and over the past decade has developed the tools and methodologies that ensures enterprises can transition to a true digital business.

AI Can Speed Design of Health Software

Retrieved on: 
Wednesday, March 6, 2024

NEW YORK, March 6, 2024 /PRNewswire/ --Publishing online March 6 in the Journal of Medical Internet Research, the study examined the capabilities of a form of artificial intelligence (AI) called generative AI or GenAI, which predicts likely options for the next word in any sentence based on how billions of people used words in context on the internet. A side effect of this next-word prediction is that the generative AI "chatbots" like chatGPT can generate replies to questions in realistic language, and produce clear summaries of complex texts.

Key Points: 
  • Led by researchers at NYU Langone Health, the current paper explores the application of ChatGPT to the design of a software program that uses text messages to counter diabetes by encouraging patients to eat healthier and get exercise.
  • The team tested whether AI-enabled interchanges between doctors and software engineers could hasten the development of such a personalized automatic messaging system ( PAMS ).
  • If this proves to be effective at scale it could revolutionize healthcare software design."
  • AI could take software design only so far before human software developers were needed for final code generation, but the overall process was greatly accelerated, say the authors.